To say the life sciences sector has been a vital part of our response to the Covid crisis would be a huge understatement.

Pharma businesses have been at the forefront of developing life-saving vaccines. However, they’ve also got the uncertainty of Brexit to contend with as well as another important issue to address – the fast-approaching changes to IR35 legislation.

Our Commercial Director, Charlie Cox, has been speaking to leading life sciences publication Pharma Times about the changes. He discusses what the sector can do to prepare for IR35 reform and stresses that if businesses want to remain competitive then they have to start getting ready now.

Charlie said: “The pharmaceutical sector has always been a competitive place, perhaps even more so of late due to the pandemic, making it especially important for clients to put the correct education, processes and procedures in place to continue to attract the best contract workers.

“With an increase in demand for contractors with sectoral expertise to come in and supply short term projects, it’s now vital that businesses have a pragmatic approach to the changes, a clear plan in place and communicate this clearly.”

You can read Charlie’s article in full here.